Literature DB >> 2304643

Central control of the sensory afferent terminals from a leg chordotonal organ in crayfish in vitro preparation.

D Cattaert1, A elManira, A Marchand, F Clarac.   

Abstract

In an in vitro preparation of the crayfish thoracic locomotor system, intracellular recordings have been performed from terminals of a leg joint coxo-basipodite chordotonal organ (CB). In the terminals, some depolarizing events are observed which display all the characteristics of the primary afferent depolarizations (PADs). PADs reduce the amplitude of orthodromic sensory spikes, and thus correspond to a presynaptic inhibition. PADs are tonic in a tonic preparation, and phasic (phase locked) in a rhythmic preparation. A control of the incoming information from the CB could thus be performed by the central nervous system during fictive locomotion.

Entities:  

Mesh:

Year:  1990        PMID: 2304643     DOI: 10.1016/0304-3940(90)90710-q

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Effects of leg movements on the synaptic activity of descending statocyst interneurons in crayfish, Procambarus clarkii.

Authors:  N Hama; M Takahata
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2003-10-31       Impact factor: 1.836

2.  Modification of statocyst input to local interneurons by behavioral condition in the crayfish brain.

Authors:  N Hama; M Takahata
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2005-04-22       Impact factor: 1.836

Review 3.  Invertebrate presynaptic inhibition and motor control.

Authors:  F Clarac; D Cattaert
Journal:  Exp Brain Res       Date:  1996-11       Impact factor: 1.972

4.  A network model comprising 4 segmental, interconnected ganglia, and its application to simulate multi-legged locomotion in crustaceans.

Authors:  M Grabowska; T I Toth; C Smarandache-Wellmann; S Daun-Gruhn
Journal:  J Comput Neurosci       Date:  2015-04-23       Impact factor: 1.621

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.